Drug Shortage Report for LUPRON DEPOT
Report ID | 99576 |
Drug Identification Number | 02230248 |
Brand name | LUPRON DEPOT |
Common or Proper name | Lupron depot 22.5mg |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | LEUPROLIDE ACETATE |
Strength(s) | 22.5MG |
Dosage form(s) | POWDER FOR SUSPENSION, SUSTAINED-RELEASE |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 syringe (22.5mg) |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-11-21 |
Actual start date | 2019-11-21 |
Estimated end date | 2019-12-06 |
Actual end date | 2019-12-06 |
Shortage status | Resolved |
Updated date | 2019-12-07 |
Company comments | We are pleased to share that this dossier has been resolved as per expected due date and orders are now being processed as per our normal process. Thank you for your continued partnership |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-23 | English | Compare |
v2 | 2019-11-23 | French | Compare |
v3 | 2019-12-06 | English | Compare |
v4 | 2019-12-06 | French | Compare |
v5 | 2019-12-07 | English | Compare |
Showing 1 to 5 of 5